Status:
COMPLETED
Qidong Hepatitis B Intervention Study
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Qidong Liver Cancer Institute
Conditions:
Hepatitis B
Liver Neoplasms
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
During 1983-1990 in the Jiangsu province of China, 80,000 infants were randomised by area of birth between control, standard Hepatitis B vaccination (at 0, 1 and 6 months of age) and standard vaccinat...
Eligibility Criteria
Inclusion
- all infants born in Qidong between September 1983 and November 1990
Exclusion
- \-
Key Trial Info
Start Date :
September 1 1983
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
80000 Patients enrolled
Trial Details
Trial ID
NCT00222664
Start Date
September 1 1983
End Date
December 1 2004
Last Update
September 22 2005
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Qidong Liver Cancer Institute
Qidong, Jiangsu, China
2
Cancer Institute, Chinese Academy of Medical Sciences
Beijing, China
3
Clinical Trial Service Unit and Epidemiological Studies Unit
Oxford, United Kingdom, OX3 7LF